Australia's Resonance Health jumps on contracts for clinical services

Resonance Health

11/11/2022 02:49

** Shares of Resonance Health Ltd  RHT.AX  rise as much as
7.7% to A$0.07, on track for best day since Oct. 27
    ** Medical tech firm says it got contracts to provide
services for two clinical trials for ~A$1.5 mln
($989,100.00) urn:newsml:reuters.com:*:nASX2DxLKP
    ** Says contract is with 2 pharmaceutical customers to
provide FerriScan, Cardiac-T2 and related analysis services for
clinical trials
    ** FerriScan, Cardiac-T2 are co's
software-as-medical-devices used to examine iron-overload in
blood 
    ** More than 259,851 shares change hands, vs the 30-day
average volume of 169,872 shares
    ** Stock down 53.6% this year, as of last close
    ($1 = 1.5165 Australian dollars)
 (Reporting by Poonam Behura in Bengaluru)
 ((Poonam.Behura@thomsonreuters.com;))